Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy
Year: 2025
Type: article
Language: en
Topic: Prostate Cancer Treatment and Research
Authors and affiliations:
raw_author_name: Flavien Devaux
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Kareem Beltagi
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Thomas Frank Ermler
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Sven Gerlach
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Anna Herrmann
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Jennifer Kranz
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Radu Alexa
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Agnieszka Morgenroth
raw_affiliation_strings: Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Andreas Theodor Josef Vogg
raw_affiliation_strings: Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Laura Schäfer
raw_affiliation_strings: Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Najaf Mammadbayli
raw_affiliation_strings: Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Matthias Saar
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany
raw_author_name: Marco Hoffmann
raw_affiliation_strings: Department of Urology and Pediatric Urology, University Hospital RWTH Aachen, Aachen, Germany; Center for Integrated Oncology (CIO), University Hospital RWTH Aachen, Aachen, Germany. Electronic address: marchoffmann@ukaachen.de